We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$2.15B
Cap. Flow
+$1.73B
Cap. Flow %
35.86%
Top 10 Hldgs %
70.13%
Holding
71
New
9
Increased
19
Reduced
13
Closed
13

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$82.8M
2
VYX icon
NCR Voyix
VYX
+$57.3M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$48.3M
4
QDEL icon
QuidelOrtho
QDEL
+$46.2M
5
VTRS icon
Viatris
VTRS
+$41.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$100M
2
HTZ icon
Hertz
HTZ
+$63.3M
3
NRG icon
NRG Energy
NRG
+$50.8M
4
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
+$38.5M
5
FLR icon
Fluor
FLR
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.51%
2 Financials 5.41%
3 Technology 4.91%
4 Energy 4.01%
5 Materials 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
51
Cullinan Oncology
CGEM
$1.26B
$6.39M 0.13%
626,929
– –
MYPS icon
52
PLAYSTUDIOS Inc
MYPS
$72.1M
$5.31M 0.11%
1,961,184
– –
BCYC
53
Bicycle Therapeutics
BCYC
$284M
$3.71M 0.08%
205,423
– –
SPRY icon
54
ARS Pharmaceuticals
SPRY
$601M
$3.5M 0.07%
639,203
– –
TXMD icon
55
TherapeuticsMD
TXMD
$24.1M
$2.68M 0.06%
1,192,191
– –
CHRS icon
56
Coherus Oncology
CHRS
$181M
$1.32M 0.03%
+395,207
New +$1.06M
VINC
57
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$418K 0.01%
17,719
– –
AHCO icon
58
AdaptHealth
AHCO
$770M
– –
-1,961,199
Closed -$17.8M
CCJ icon
59
Cameco
CCJ
$43.1B
– –
-2,523,540
Closed -$100M
CCO icon
60
Clear Channel Outdoor Holdings
CCO
$1.23B
– –
-6,705,943
Closed -$10.6M
CNDT icon
61
Conduent
CNDT
$241M
– –
-834,660
Closed -$2.9M
HTZ icon
62
Hertz
HTZ
$998M
– –
-5,165,254
Closed -$63.3M
IMVT icon
63
PUT
Immunovant
IMVT
$8.8B
– –
-569,800
Closed -$21.9M
IWM icon
64
PUT
iShares Russell 2000 ETF
IWM
$82.2B
– –
-1,500,000
Closed -$265M
MGNI icon
65
Magnite
MGNI
$3.49B
– –
-4,000,000
Closed -$30.2M
MSGS icon
66
Madison Square Garden
MSGS
$9.97B
– –
-83,512
Closed -$14.7M
MX icon
67
Magnachip Semiconductor
MX
$139M
– –
-967,867
Closed -$8.04M
NRG icon
68
NRG Energy
NRG
$25.4B
– –
-1,318,020
Closed -$50.8M
VST icon
69
Vistra
VST
$49.2B
– –
-602,189
Closed -$20M
HOLI
70
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
– –
-1,941,237
Closed -$38.5M
1 2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2023 Portfolio in Review

As of Q4 2023, Rubric Capital Management (New York) held 71 positions worth $4.82B, up 81% from $2.67B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Rubric Capital Management (New York) deployed $1.73B of net new capital in Q4 2023, opening 9 new positions and adding to 19 existing holdings. Its largest new stake was NCR Voyix: 3,591,228 shares worth $60.7M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 36% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Fluor, an estimated $32.1M trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2023 buy was NCR Voyix: 3,591,228 shares worth $60.7M.
  • Rubric Capital Management (New York) added most to Roivant Sciences in Q4 2023, an estimated $82.8M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2023 reduction was Fluor, cutting an estimated $32.1M.
  • Rubric Capital Management (New York) fully exited Cameco in Q4 2023, selling an estimated $100M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 70% of its $4.82B portfolio in Q4 2023.
  • Rubric Capital Management (New York) opened 9 new positions and closed 13 in Q4 2023.
  • Rubric Capital Management (New York)'s portfolio value rose 81% quarter-over-quarter to $4.82B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2023, filed 13 Feb 2024.